AIG
CBIO

American International Group’s Crescent Biopharma CBIO Stock Holding History

American International Group’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-216
Closed -$65K – 3186
2021
Q1 		$65K Buy
216
+1
+0.5% +$358 ﹤0.01% 2906
2020
Q4 		$81K Sell
215
-7
-3% -$2.45K ﹤0.01% 2757
2020
Q3 		$68K Buy
222
+15
+7% +$5.73K ﹤0.01% 2737
2020
Q2 		$78K Buy
207
+7
+4% +$1.98K ﹤0.01% 2680
2020
Q1 		$46K Sell
200
-12
-6% -$4.59K ﹤0.01% 2712
2019
Q4 		$112K Sell
212
-2
-0.9% -$1.08K ﹤0.01% 2562
2019
Q3 		$92K Sell
214
-1
-0.5% -$643 ﹤0.01% 2658
2019
Q2 		$256K Sell
215
-2
-0.9% -$2.39K ﹤0.01% 2078
2019
Q1 		$271K Sell
217
-7
-3% -$8.02K ﹤0.01% 2041
2018
Q4 		$212K Sell
224
-2
-0.9% -$2.41K ﹤0.01% 2154
2018
Q3 		$325K Buy
226
+7
+3% +$10.6K ﹤0.01% 2131
2018
Q2 		$353K Buy
+219
New +$377K ﹤0.01% 2041
2017
Q2 		– Sell
-64
Closed -$35K – 3092
2017
Q1 		$35K Buy
64
+5
+8% +$3.07K ﹤0.01% 2901
2016
Q4 		$36K Hold
59
– – ﹤0.01% 2913
2016
Q3 		$42.2K Hold
59
– – ﹤0.01% 2932
2016
Q2 		$42.9K Buy
+59
New +$40.6K ﹤0.01% 2984

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American International Group's CBIO Position: Q2 2021 in Review

American International Group sold out of Crescent Biopharma (CBIO) in Q2 2021, closing a stake of 216 shares — an estimated $65K sold.

American International Group first reported a position in CBIO in Q2 2016 and held it in 16 quarters. The position peaked at $353K in Q2 2018. 58 funds tracked by Wall St. Rank hold CBIO as of Q2 2021.

  • American International Group reported no remaining Crescent Biopharma position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 216 Crescent Biopharma shares in Q2 2021, an estimated $65K.
  • American International Group first reported a position in Crescent Biopharma in Q2 2016 and held it in 16 quarters.
  • American International Group's Crescent Biopharma position peaked at $353K in Q2 2018.
  • 58 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.